4Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol, 2006,48( 12 ) :2584-2591.
5Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease : a meta-analysis. Eur Heart J, 2006,27(23) :2784-2814.
6Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med,2006,355(11) : 1093-1104.
7Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med, 2006,355 ( 11 ) : 1105-1113.
8Suttorp MJ, Lain-man GJ, Rahel BM, et al. Primary Stenting of Totally Occluded Native Coronary Arteries Ⅱ (PRISON Ⅱ). A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation, 2006,114 (9) :921-928.
9Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation, 2006, 114(18) : 1955-1961.
10Keeley EC, Boura JA, Gfines CL Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials.Lancet, 2006,367 (9510) : 579-588.
